<DOC>
	<DOCNO>NCT02656914</DOCNO>
	<brief_summary>The purpose study evaluate non inferiority clinical efficacy drug association treatment flu symptom</brief_summary>
	<brief_title>Comparison EMS Association Resfenol® Treat Flu Symptoms</brief_title>
	<detailed_description>Open-label , randomize , multicenter ; Maximal experiment duration : 10 day ; 03 visit ; Safety efficacy evaluation</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Participant within 72 hour onset flu symptom , accord Ministry Health Protocol ( 2013 ) ; Signed Consent patient ; Participant whose tutor capacity understand consent child 's participation clinical study , manifest signing TCLE Patients clinically significant disease investigator opinion can´t participate study ; Patients laboratory find image find investigator opinion can´t participate clinical trial ; Patients history hypersensitivity formula compound ; Participation clinical trial year prior study ; Patients vaccine reaction ; Patients uncontrolled asthma however , participant use pulmonary corticosteroid ( alone combination product ) allow stable dose diagnose controlled asthma ; Patients gastroesophageal reflux , gastric duodenal ulcer serious disease gastrointestinal tract ; Patients diabetes mellitus type I II ; Pregnancy risk pregnancy lactate patient ; Patients use drug interfere flu symptom evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>